Workflow
安必平(688393) - 2024 Q3 - 季度财报
LBPMedicineLBPMedicine(SH:688393)2024-10-30 09:11

Financial Performance - The company's operating revenue for Q3 2024 was ¥124,610,061.39, a decrease of 13.20% compared to the same period last year[2] - Net profit attributable to shareholders for Q3 2024 was ¥13,268,104.86, down 31.92% year-on-year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 43.15% to ¥12,217,889.69 in Q3 2024[3] - Basic earnings per share for Q3 2024 were ¥0.14, a decline of 33.33% compared to the previous year[3] - Total operating revenue for the first three quarters of 2024 was CNY 352,677,214.95, a decrease of 0.23% compared to CNY 354,506,458.37 in the same period of 2023[14] - Net profit for the first three quarters of 2024 was CNY 23,186,880.84, compared to CNY 18,830,785.55 in the same period of 2023, representing a year-on-year increase of 23.5%[15] - Earnings per share for the first three quarters of 2024 were CNY 0.32, down from CNY 0.40 in the same period of 2023[16] - The company reported a total profit of CNY 19,905,577.50 for the first three quarters of 2024, slightly down from CNY 20,439,059.92 in the same period of 2023[15] Research and Development - Total R&D investment for Q3 2024 was ¥12,513,897.25, a decrease of 40.64% year-on-year[3] - Research and development expenses decreased significantly to CNY 29,892,092.67, down 33.1% from CNY 44,604,725.21 in the previous year[14] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,375,771,762.47, a decrease of 1.73% from the end of the previous year[3] - The company's current assets totaled CNY 660,884,005.26, up from CNY 567,569,652.46 in the previous period, indicating a growth of approximately 16.4%[11] - Accounts receivable increased to CNY 248,716,964.96 from CNY 235,547,368.05, reflecting a growth of about 5.2%[9] - Inventory rose to CNY 87,266,654.02, compared to CNY 74,972,461.19, marking an increase of approximately 16.4%[11] - The total liabilities decreased to CNY 125,714,536.99 from CNY 161,626,457.80, representing a reduction of about 22.2%[12] - The non-current assets totaled CNY 714,887,757.21, down from CNY 832,361,320.28, indicating a decrease of about 14.1%[11] - The total equity remained stable at CNY 93,567,699.00, unchanged from the previous period[12] - The total liabilities and equity amounted to CNY 1,375,771,762.47, a decrease from CNY 1,399,930,972.74 in the previous period[13] Cash Flow - The company reported a net cash flow from operating activities of ¥3,694,532.03, an increase of 15.09% year-to-date[2] - The net cash flow from operating activities for Q3 2024 was CNY 3,694,532.03, an increase from CNY 3,210,037.42 in Q3 2023, reflecting a growth of approximately 15.1%[18] - Cash flow from operating activities increased to CNY 374,494,566.67, compared to CNY 361,131,309.52 in the first three quarters of 2023, reflecting a growth of 3.7%[17] - The cash flow from investment activities turned positive with a net cash flow of CNY 9,326,160.04 in Q3 2024, compared to a negative cash flow of CNY 15,856,588.49 in Q3 2023[18] - Total cash inflow from investment activities decreased to CNY 100,674,644.99 in Q3 2024 from CNY 204,781,321.19 in Q3 2023, representing a decline of about 50.9%[18] - The net cash flow from financing activities showed a significant negative change, with a net outflow of CNY 35,851,773.85 in Q3 2024 compared to a net outflow of CNY 15,888,900.14 in Q3 2023[19] - Cash and cash equivalents at the end of Q3 2024 were CNY 44,769,947.30, down from CNY 61,388,563.04 at the end of Q3 2023, indicating a decrease of approximately 27%[19] - The company received CNY 93,144,872.00 from investment recoveries in Q3 2024, a decrease from CNY 195,240,000.00 in Q3 2023, marking a decline of about 52.3%[18] - Cash paid for purchasing goods and services increased to CNY 119,639,075.48 in Q3 2024 from CNY 104,880,151.76 in Q3 2023, reflecting an increase of approximately 14.1%[18] - The cash outflow for financing activities rose to CNY 51,126,773.85 in Q3 2024, compared to CNY 29,072,533.55 in Q3 2023, indicating an increase of about 75.9%[19] - The company reported a cash inflow from financing activities of CNY 15,275,000.00 in Q3 2024, up from CNY 13,183,633.41 in Q3 2023, which is an increase of approximately 15.8%[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 6,014[6] - The largest shareholder, Cai Xiangting, held 21.18% of the shares, totaling 19,817,000 shares[6] - The company has not reported any significant changes in its major shareholders or their participation in margin trading activities[8]